Bench-to-Bedside: How Basic and Clinical Scientists can work to improve drug safety and efficacy

Here is your daily, non-COVID, non-US election, non-massive world ending disaster post for the day. It's nice to get something like this these days. If you look at the common pathway of drug development, you will notice something like this: Pre-clinical -> Phase I -> Phase II -> Phase II -> Phase IV. Without going [...]

Virtual Conferences: How will conferencing change after COVID?

Many of us were getting ready for spring conference season when COVID hit. Now, however, we need to look to the future of conferencing and consider what will change when it comes to conferencing post COVID. Will anything Change? My answer to this... absolutely not. I think people will be so anxious to get outside [...]

Scientist – The most valuable skillset in the COVID-19 pandemic

A Difficult Time For Scientists By now the majority of academic STEM researchers have shut down their labs in response to the COVID-19 pandemic. As a 5th year PhD student, this was definitely not the challenge I was expecting to be my last hurdle in earning my PhD. I have seen many stories that have [...]

Data Management of the Future: Electronic Lab Notebooks.

Are you prepping your virtual classrooms this week? What about lab meetings? Virtual meetings such as Zoom allow for communicating across the globe, but what about data sharing? In the era of big data generation and management it is getting harder to simply share an Excel file with a simple data set. Large high quality [...]

Should Financial Literacy Be Part of Graduate School Curriculums?

How are grants coming so far this year? Most scientists hate this question. Funding in the biosciences has always been a tooth and nail battle for most academic researchers. However, are we exacerbating this problem by the way we are teaching in graduate school? Very few graduate programs actually teach their students proper financial literacy [...]